TUDOR INVESTMENT CORP ET AL - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$1,390,202
-43.5%
72,331
-25.3%
0.01%
-51.7%
Q2 2023$2,459,944
+131167.0%
96,772
+86.7%
0.03%0.0%
Q1 2023$1,874
-31.8%
51,839
-25.3%
0.03%
-46.3%
Q4 2022$2,748
-98.7%
69,382
+1348.5%
0.05%
+800.0%
Q2 2022$210,000
-90.3%
4,790
-83.9%
0.01%
-88.0%
Q1 2022$2,154,000
+91.8%
29,776
+115.0%
0.05%
+163.2%
Q4 2021$1,123,000
+379.9%
13,847
+881.4%
0.02%
+375.0%
Q2 2021$234,000
-83.9%
1,411
-83.2%
0.00%
-90.2%
Q4 2020$1,456,000
+600.0%
8,411
+464.1%
0.04%
+355.6%
Q3 2020$208,000
-83.1%
1,491
-85.5%
0.01%
-85.2%
Q2 2020$1,232,000
+66.5%
10,313
+39.4%
0.06%
-7.6%
Q1 2020$740,000
+220.3%
7,399
+276.3%
0.07%
+560.0%
Q4 2019$231,000
-65.5%
1,966
-88.6%
0.01%
-23.1%
Q4 2018$670,000
-26.2%
17,236
+8.2%
0.01%
-43.5%
Q3 2018$908,000
+78.7%
15,926
+150.3%
0.02%
+27.8%
Q2 2018$508,000
-1.7%
6,362
+6.7%
0.02%
+5.9%
Q1 2018$517,000
+153.4%
5,961
+101.5%
0.02%
+240.0%
Q4 2017$204,000
-86.8%
2,958
-85.7%
0.01%
-89.4%
Q2 2017$1,540,000
+255.7%
20,685
+347.1%
0.05%
+261.5%
Q1 2017$433,000
-46.6%
4,626
-58.6%
0.01%
-38.1%
Q4 2016$811,000
-41.2%
11,164
-15.6%
0.02%
-34.4%
Q3 2016$1,380,000
+432.8%
13,221
+276.2%
0.03%
+540.0%
Q2 2016$259,000
-37.7%
3,514
-52.5%
0.01%
-54.5%
Q1 2016$416,000
-31.6%
7,400
-43.5%
0.01%
-47.6%
Q3 2015$608,00013,1000.02%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders